当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Patients with porphyria bask in sunlight of FDA approval.
Nature Biotechnology ( IF 33.1 ) Pub Date : 2019-12-01 , DOI: 10.1038/s41587-019-0347-0
Mark Ratner 1
Affiliation  

The US regulator’s go-ahead is a boon for people with a rare form of porphyria that results in painful photosensitivity.

中文翻译:

卟啉症患者在FDA批准的阳光下晒太阳。

美国监管机构的批准对患有罕见的卟啉症会导致痛苦的光敏性的人来说是福音。
更新日期:2019-12-04
down
wechat
bug